منابع مشابه
Alternatives to mifepristone for early medical abortion.
OBJECTIVE To review published reports of first-trimester medical abortion regimens that do not include mifepristone. METHODS Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990. RESUL...
متن کاملEarly medical abortion at home.
Cameron et al.1 report on a pilot of early medical abortion in a group of women with pregnancies less than 8 weeks. They demonstrated good patient experiences and high levels of satisfaction in this group of women; in the immediate aftermath of the abortion. I do, however, have serious concerns regarding their administration of mifepristone right away, on the same day, following patient assessm...
متن کاملEarly medical abortion at home.
We write in support of using mifepristone at the fi rst visit for early medical abortion (EMA), without an obligatory cooling-off period.1 In our service in South East Wales, we have been providing home EMA since 2007 in a setting very similar to that described in the pilot study reported by Cameron et al.2 Similarly, patients attending our service are able to have mifepristone administered at ...
متن کاملWomen's experiences of having an early medical abortion at home.
OBJECTIVES The aim of this study was to assess women's experiences of having an early medical abortion at home and to investigate their perceptions of the information provided before the abortion. The study also aimed to investigate possible differences between groups of women. STUDY DESIGN The study is cross-sectional with a descriptive and comparative design. Semi-structured telephone inter...
متن کاملEarly medical abortion: legal and medical developments in Australia.
Mifepristone is a safe, effective and relatively cheap drug that plays an important role in women's health care and is widely used for early medical abortion in many countries. The Therapeutic Goods Administration (TGA) can authorise mifepristone to be imported into and marketed in Australia. To date, no pharmaceutical company has applied to register mifepristone in Australia. The TGA can also ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Taiwanese Journal of Obstetrics and Gynecology
سال: 2011
ISSN: 1028-4559
DOI: 10.1016/j.tjog.2011.01.001